Get the Stockscreener App
113.02
0.43%
0.48
After Hours:
113.02
Zimmer Biomet Holdings Inc stock is traded at $113.02, with a volume of 1.86M.
It is up +0.43% in the last 24 hours and up +6.31% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$112.54
Open:
$112.7
24h Volume:
1.86M
Relative Volume:
1.30
Market Cap:
$22.50B
Revenue:
$7.60B
Net Income/Loss:
$1.08B
P/E Ratio:
46.90
EPS:
2.41
Net Cash Flow:
$1.26B
1W Performance:
+3.25%
1M Performance:
+6.31%
6M Performance:
-5.96%
1Y Performance:
+1.21%
1-Day Range:
$112.64
$114.72
1-Week Range:
$108.25
$114.72
52-Week Range:
$101.47
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| ZBH | 113.02 | 22.50B | 7.60B | 1.08B | 1.26B | 2.41 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Zimmer Biomet's Leading Knee Revision System Gains CE Mark for European Expansion | ZBH Stock News - StockTitan
Corbyn Investment Management Inc. MD Grows Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Equity Investment Corp Invests $70.10 Million in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Thrivent Financial for Lutherans Trims Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ING Groep NV Sells 90,246 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
UBS: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Is A Bottom-Ranked Quant Stock - Yahoo Finance
Sumitomo Mitsui Trust Group Inc. Has $52.03 Million Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives $123.22 Consensus Target Price from Analysts - MarketBeat
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Sivik Global Healthcare LLC Makes New $4.32 Million Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, growth plans - Investing.com Australia
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Position Lessened by Assetmark Inc. - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer - MultiVu
Arnold Schwarzenegger Joins Zimmer Biomet as Chief Movement Officer in Landmark Partnership | ZBH Stock News - StockTitan
Principal Financial Group Inc. Sells 26,515 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. Appoints Arnold Schwarzenegger as Chief Movement Officer - Marketscreener.com
Victory Capital Management Inc. Reduces Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Janney Montgomery Scott LLC Buys 16,663 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Announces Leadership Transition - GuruFocus.com
Versor Investments LP Raises Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues - Yahoo Finance
Knee Replacement Market Is Booming Worldwide 2024-2031 | Zimmer - openPR
River Global Investors LLP Acquires 5,030 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Costello Asset Management INC - MarketBeat
Robeco Institutional Asset Management B.V. Sells 125,363 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
M&G Plc Acquires 21,251 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors - The Manila Times
Leeward Investments LLC MA Decreases Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to Present at Jefferies London Healthcare Conference – Company Announcement - Financial Times
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality - Simply Wall St
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Position Boosted by National Pension Service - MarketBeat
Stephens Inc. AR Makes New $638,000 Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Bought by Heritage Investors Management Corp - MarketBeat
Zimmer Biomet falls on potential revenue hit from software issue - MSN
Royal Bank of Canada Issues Positive Forecast for Zimmer Biomet (NYSE:ZBH) Stock Price - MarketBeat
NeuroOne agree $3m partnership with Zimmer Biomet - Medical Device Network
Zimmer licenses NeuroOne brain ablation system - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by US Bancorp DE - MarketBeat
Zimmer Biomet Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2015; Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2016 - Marketscreener.com
Roth Capital Decreases Earnings Estimates for Zimmer Biomet - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) Expands with NeuroOne Alliance and Z1 Hip System Launch - Yahoo Finance
Van ECK Associates Corp Boosts Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet reports increased net sales in third-quarter 2024 financial results - Healio
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Simply Wall St
Zimmer Biomet Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Zimmer Biomet net sales surge 4% to USD 1.824B in Q3 2024 - Medical Buyer
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):